Switch to Dark

Pricing

Learn

BSX - Boston Scientific Corp

119

$71.20

$1.41 (2.020%)

At market close

$71.50

$0.30 (0.418%)

After Hours 3/17/26, 10:45 PM

Score

4.04/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Metric Margins Overview

Metrics

KPIs

View as %

Boston Scientific Corp

Stock Unlock

Legend	CAGR	Total Change	Average	Median	Low	High	Latest
Operating Margin	7.64%	5.7%	19.21%	19.12%	18.69% 2025-06-30	19.92% 2025-12-31	19.92% 2025-12-31

Net Margin	34.04%	24.7%	13.5%	13.98%	11.58% 2025-03-31	14.44% 2025-12-31	14.44% 2025-12-31

Gross Margin	0.52%	0.4%	68.65%	68.65%	68.3% 2025-06-30	69.01% 2025-12-31	69.01% 2025-12-31

Free Cash Flow Margin	8.2%	6.12%	18.5%	18.53%	17.17% 2025-03-31	19.76% 2025-09-30	18.22% 2025-12-31

Income Statement

Balance Sheet

Cash Flow

Metrics

KPIs

% Change

Colors

#'s in thousands USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31 Get more features by creating a free Stock Unlock account: 2 portfolios, 5 positions per portfolio 2 watchlists, up to 10 tickers per watchlist More screener searches See full feature list	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Margins
Gross Margin	69.01%	68.57%	68.30%	68.73%	42K%	9278483	6748785	5932639	618279	497972	6152260	3831389	3358941	2820482	2512679	4131528	4427518	4081044
SGA Margin	34.31%	34.45%	35.08%	35.42%	42K%	4356678	326253	3082102	7015642	8005529	6126021	674054	743831	5048714	6859254	4979098	9291275	2527904
Operating Margin	19.92%	19.40%	18.69%	18.85%	42K%	2295047	9674249	345497	7399819	1261772	6785092	3260638	2573446	3384297	7357904	6150929	1235192	5553993
EBITDA Margin	26.73%	26.38%	25.80%	26.19%	42K%	9380056	2531534	2714701	4527916	6799894	8404764	2981688	90565	8329136	8025359	9495836	5529243	1217688
Net Margin	14.44%	14.42%	13.54%	11.58%	42K%	716376	6353002	1157242	1848372	5252581	2612030	2175087	8442596	4101363	3478775	6491489	4324451	8957323
Free Cash Flow Margin	18.22%	19.76%	18.84%	17.17%	42K%	7183762	8203494	1071060	1000145	4657071	4184114	640795	139536	6734388	3495063	4530453	9919838	9516878
Operating Cash Flow Margin	22.59%	23.90%	23.16%	21.72%	42K%	3448002	3867152	7880298	2884704	3857299	5759546	2986682	8998559	9878494	3291412	7557366	2301242	6517072
Valuation Metrics
Market Cap	141,350,840	144,663,400	158,907,330	149,208,600	42,069,000	2047809	8141563	2802117	7456290	3974821	7928531	6986674	4768498	1653970	3260564	3315904	2061917	6952731
Enterprise Value	150,821,840	154,988,400	169,960,330	159,792,600	42,069,000	1478386	3546575	8133370	1218410	1750270	8722538	8679822	6485902	1326006	960165	3045448	3845668	6685269
Price to Sales	7.04	7.48	8.59	8.5	42,069	2214423	3609125	4726169	5343217	3684882	3266625	275591	6966199	1244364	1958841	3185216	5287100	6645449
Price to Gross	10.2	10.9	12.58	12.37	42,069	1662378	4236378	7562614	3090030	3199252	9150996	6906159	8262123	7657219	8102730	1681871	3770258	2890025
Price to Operating Cash Flow	31.18	31.28	37.09	39.14	42,069	7035500	3128092	5624782	5294314	4725528	8649423	9757707	3512815	7463781	5390293	6108839	1648909	321712
Price to Operating Income	35.35	38.54	45.97	45.11	42,069	4608065	9120483	922261	2553198	7209774	9969497	1172950	3709466	3793563	6246383	4142211	267693	4794563
Price to Earnings	48.78	51.83	63.44	73.43	42,069	9158422	8046430	6035412	635105	7016976	6368367	718491	7548841	6081059	1477813	3610740	8176611	8558166
Price to Free Cash Flow	38.64	37.84	45.61	49.51	42,069	8319285	9145609	5429805	6072365	4248736	2784474	3456549	6530799	9045859	7937787	4296088	653926	6788296
Management
Return On Assets	6.64%	6.54%	6.03%	5.06%	42K%	8396957	5255383	3904816	4163763	5217916	7834602	5725712	5872255	2977659	1557519	9714814	2533779	9675804
Return On Capital Employed	10.46%	10.04%	9.51%	9.43%	42K%	2226308	831454	485074	9128577	4918619	3299010	7537405	8082360	4753575	4481371	1508647	1324472	7181908
Return On Equity	11.96%	11.93%	11.17%	9.15%	42K%	1401364	7678105	3962188	2438121	7393639	9452331	6700170	8296330	7999297	2926796	7210332	4459572	8547624
Return On Invested Capital	10.41%	9.69%	8.83%	8.70%	42K%	5830066	71143	7252050	3079224	1759330	7836632	8153757	7345100	9218191	2567016	128809	7310376	7505073
Stock Based Compensation
SBC as a % of FCF	8.17%	7.77%	4.51%	9.19%	42K%	6423355	664842	249614	9090514	282349	5303943	1001410	7955673	4150128	975862	6671798	8447441	7105394
SBC as a % of OCF	6.59%	6.42%	3.66%	7.27%	42K%	7622264	781873	4977555	4459105	5572657	7798549	5279149	1039574	5113299	8049761	387556	4228741	9067116
SBC as a % of Revenue	1.49%	1.53%	0.85%	1.58%	42K%	249938	4463580	5497646	1978963	5169071	5500004	9931740	6352746	8265568	8094743	3227807	6345686	27702
FCF Excl. SBC Yield	2.38%	2.44%	2.09%	1.83%	42K%	8379333	6155580	814345	7798142	4995097	121646	533393	4306327	3648321	7120257	1687411	9255990	6699893
Per Share
Free Cash Flow Per Share	2.45	2.56	2.33	2.02	42,069	7090641	9668548	5232575	2996783	1733449	4078202	4046143	2234848	4882748	4152190	637161	742945	8423414
Operating Cash Flow Per Share	3.03	3.09	2.87	2.55	42,069	3057848	9324160	4404819	8175102	3572355	9514299	8494060	1303842	5483784	9197210	7887494	3172152	3162674
Revenue Per Share	13.42	12.94	12.38	11.76	42,069	779632	9605140	8698528	9764610	1167682	9981967	361218	2969979	6940927	2156194	3954181	5990797	5333320
Financial Health
Debt to EBITDA Ratio	2.13	2.27	2.43	2.46	42,069	6489385	2841313	4427781	6700472	8245549	8384051	2444468	4743422	3360169	5243790	3177773	8348668	3899881
Interest Coverage Ratio	11.46	11.07	10.44	10.4	42,069	7931225	7111972	6421253	8935208	5047624	4496221	1484769	8413405	4108002	9012795	5914193	6711562	5705864
Net Debt	9,471,000	10,325,000	11,053,000	10,584,000	42,069,000	7501652	4997714	5121114	1617264	7725599	7661062	4676171	5955351	9693602	9762694	8881011	8242718	1181695
Total Debt	11,436,000	11,600,000	11,587,000	11,309,000	42,069,000	3614298	5470830	2678298	5832468	1230070	2496380	513046	5445114	4136853	6874005	7495601	1653963	5321364